Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought
Cathie Wood's success is based on two main things: finding innovators and betting on them for the long term. The founder and chief executive officer of Ark Invest goes for innovators in all areas, from information technology to healthcare, and this helped her flagship Ark Innovation fund outperform the S 500 Index by a mile last year. Ark Innovation soared 67%, which the benchmark index advanced 24%.
One of Wood's favorite technologies, in the area of healthcare, is gene editing, and last week, she increased her bet by adding to her holdings in two top players: CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA). The former recently reached a huge milestone, and the latter is heading for several catalysts over the next two years. Let's check out these top Cathie Wood stocks.
Image source: Getty Images.
Source Fool.com
Intellia Therapeutics Inc Aktie
Mehrere Buy-Einschätzungen für Intellia Therapeutics Inc, die die Sell-Einschätzungen übersteigen.
Die Community prognostiziert für Intellia Therapeutics Inc ein Kursziel von 60 €, was den aktuellen Kurs von 18.03 € weit übertrifft.
Kommentare
